Immix Biopharma IMMX
NASDAQ IMMX
$10.54 -0.93 (-8.11%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Operating Expenses (2021 - 2026)

Updated

Immix Biopharma's Operating Expenses came in at $12.46 million for Q2 2026, up 85.4% from $6.72 million a year earlier and up 15.3% from the prior quarter.

Analysis

Immix Biopharma (IMMX) Operating Expenses (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Immix Biopharma reported Operating Expenses of $41.82 million, up 75.8% year-over-year; for FY2025, it was $29.96 million, up 32.1% from FY2024.

  • Operating Expenses has increased in each of the last five years, with a five-year compound annual growth rate of 131.2% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $22.67 million in FY2024 (+40.5%), $16.14 million in FY2023 (+96.4%), $8.22 million in FY2022 (+507.9%) and $1.35 million in FY2021 (+197.9%).
  • The Q2 2026 figure represents the highest quarterly Operating Expenses in data going back to Q1 2021.
  • Year-over-year, Operating Expenses has increased for five consecutive quarters, with growth averaging 52.6% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q1 2022 (growth of 718.4%), and the weakest in Q1 2025 (a decline of 16.2%).
  • Business Quant data shows IMMX's Operating Expenses at $10.8 million (Q1 2026), $10.89 million (Q4 2025) and $7.66 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Immix Biopharma 820.51 Mn 820.51 Mn - 12.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.46 Mn
Mar 31, 2026 10.80 Mn
Dec 31, 2025 10.89 Mn
Sep 30, 2025 7.66 Mn
Jun 30, 2025 6.72 Mn
Mar 31, 2025 4.68 Mn
Dec 31, 2024 4.99 Mn
Sep 30, 2024 7.39 Mn
Jun 30, 2024 4.70 Mn
Mar 31, 2024 5.59 Mn
Dec 31, 2023 5.38 Mn
Sep 30, 2023 4.52 Mn
Jun 30, 2023 3.72 Mn
Mar 31, 2023 2.52 Mn
Dec 31, 2022 3.79 Mn
Sep 30, 2022 1.53 Mn
Jun 30, 2022 1.56 Mn
Mar 31, 2022 1.33 Mn
Dec 31, 2021 598,338.00
Sep 30, 2021 347,991.00
API Access

Immix Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IMMX&period=max&api_key=YOUR_API_KEY